Alkermes PLC (NAS:ALKS)
$ 29.65 0.15 (0.51%) Market Cap: 4.80 Bil Enterprise Value: 4.25 Bil PE Ratio: 15.21 PB Ratio: 3.71 GF Score: 69/100

Q3 2023 Alkermes Plc Earnings Call Transcript

Oct 25, 2023 / 12:00PM GMT
Release Date Price: $21.8 (-7.39%)
Operator

Greetings, and welcome to the Alkermes Third Quarter 2023 Financial Results Conference Call. My name is Donna, and I will be your operator for today's call. (Operator Instructions) Please note that this conference is being recorded. I'll now turn the call over to Sandy Coombs, Senior Vice President of Investor Relations and Corporate Affairs. Thank you, Sandy. You may now begin.

Sandra Coombs
Alkermes plc - SVP of Corporate Affairs & IR

Good morning. Welcome to the Alkermes plc conference call to discuss our financial results and business update for the quarter ended September 30, 2023, as well as initial clinical data related to ALKS 2680 presented during this week's world Week meeting. With me today are Richard Pops, our CEO; Ian Brown, our CFO; Todd Nichols, our Chief Commercial Officer; and Dr. Craig Hopkinson, our Chief Medical Officer.

During today's call, we will be referencing slides which are available on the Investor Events section of our website. Additionally, I encourage everyone to go to the Investors section of the alkermes.com to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot